A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective. (Reuters) COVID-19 vaccineCOVID-19 pandemic link embed save